Jon Prigge

Title: Jon Prigge: Innovator in DNA Vaccine Technology

Introduction

Jon Prigge is a notable inventor based in Spring, Texas, recognized for his contributions to the field of vaccine technology. He holds a patent for a smallpox DNA vaccine that has the potential to generate a protective immune response in mammals against pox viruses. His innovative work is crucial in the ongoing fight against infectious diseases.

Latest Patents

Prigge's patent, titled "Smallpox DNA vaccine and the antigens therein that elicit an immune response," focuses on DNA vaccines capable of expressing multiple VACV MV and EV antigens. This invention outlines methods for inducing a protective immune response, including a neutralizing antibody response, through the injection of the DNA vaccine into mammalian tissue. He has been granted 1 patent for this significant advancement in immunology.

Career Highlights

Throughout his career, Jon Prigge has worked with esteemed organizations such as the University of Pennsylvania and Inovio Pharmaceuticals, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field of vaccine development.

Collaborations

Prigge has collaborated with notable colleagues, including Ruxandra Draghia-Akli and Niranjan Y Sardesai. These partnerships have contributed to the advancement of his research and the development of innovative vaccine solutions.

Conclusion

Jon Prigge's work in developing a smallpox DNA vaccine exemplifies the importance of innovation in the medical field. His contributions are paving the way for future advancements in vaccine technology and public health.